IMARC Group, a leading market research company, has recently releases report titled, “Poultry Diagnostics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028“, The study provides a detailed analysis of the industry, including the global poultry diagnostics market size, share, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.
Report Highlights:
| Report Attributes | Details |
| Market Size in 2022 | US$ 441.8 Million |
| Market Forecast in 2028 | US$ 791.2 Million |
| Growth rate (2023 to 2028) | CAGR of 10.2% |
| Base Year of the Analysis | 2022 |
| Forecast Period | 2023-2028 |
Poultry diagnostics comprise several tests conducted to diagnose poultry diseases accurately. It typically includes toxicology, clinical examination, pathology, molecular diagnostic testing, and quality assurance testing of feed ingredients to prevent infectious diseases and food infection in waterfowl, chickens, broilers, ducks, and turkeys. It helps poultry farmers to identify, prevent and treat numerous diseases such as chronic respiratory disease (CRD), infectious bronchitis (IB), avian influenza (AI), Newcastle disease (ND), and avian salmonellosis, and chicken anemia (CA) that can occur due to their lack of proper care and management and inadequate nutritious feeding of poultry birds. As a result, poultry diagnostics are widely adopted in veterinary diagnostic centers, hospitals, and clinics across the globe.
Get a PDF Sample for more detailed market insights: https://www.imarcgroup.com/poultry-diagnostics-market/requestsample
The market is primarily driven by the increasing incidences of zoonotic diseases. Additionally, the increasing poultry disease outbreaks such as avian influenza, avian mycoplasmosis, and infectious bursal disease, and the rising concerns regarding food security are contributing to the market growth. Presently, the continuous efforts to raise awareness regarding these diseases caused by numerous fungi, viruses, bacteria, protozoon pathogens, nutritional deficiencies, and environmental stress are influencing market growth. Moreover, the implementation of strict health and food safety standards and numerous favorable initiatives undertaken by governing and non-governing organizations (NGOs) to generate awareness regarding infectious diseases among poultry farmers represents another major growth-inducing factor. Besides this, the escalating demand for poultry-derived food products such as meat and eggs and the increasing awareness about the advantages of early detection of diseases and available treatment options are propelling the market growth. Along with this, the widespread adoption of enzyme-linked immunosorbent assay (ELISA) tests due to their high accuracy, sensitivity, and cost-efficiency is accelerating the product adoption rate. Additionally, the development of advanced testing tools and point of care (POC) diagnostics for newer illnesses such as mortality syndrome are providing a positive thrust to the market growth. Apart from this, the poultry diagnostics market is growing at different rates in numerous regions, with North America being one of the largest markets due to the increasing consumer awareness regarding food safety, rising consumption of poultry-derived products, and growing incidence of zoonotic diseases associated with poultry across the region. Moreover, the industry is expected to face competition in the upcoming years as numerous key players are implementing competitive strategies to sustain their presence in the market. For instance, in February 2018, BioChek introduced Avian Influenza H5-H7-H9 Multiplex, a PCR testing kit for diagnosing influenza in poultry. Furthermore, new product launches, extensive research and development (R&D) activities, and mergers and acquisitions (M&A) among key market players are creating a positive global market outlook. For instance, in July 2018, Zoetis acquired Abaxis, a global player in veterinary point-of-care testing instruments, to maintain its position in veterinary diagnosis.
The report has segmented the market into the following categories:
Breakup by Disease Type:
Breakup by Test Type:
Breakup by Service:
Breakup by Region:
The report covers the major market players including:
Ask Analyst for Customized Report: https://www.imarcgroup.com/request?type=report&id=4381&flag=C
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.
Contact us:
IMARC Group
Email: sales@imarcgroup.com
USA: +1-631-791-1145 | Asia: +91-120-433-0800
Address: 134 N 4th St. Brooklyn, NY 11249, USA
Website: https://www.imarcgroup.com/
Follow us on Twitter: @imarcglobal
Linkedin: https://www.linkedin.com/company/imarc-group
